| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| BMY 施貴寶 | 6,311,000,000.0 | 5,991,000,000.0 | 3,115,000,000.0 |
| GILD 吉利德科學 | 4,108,000,000.0 | 3,961,000,000.0 | 2,187,000,000.0 |
| AMGN 美國安進 | 4,684,000,000.0 | 4,248,000,000.0 | 1,417,000,000.0 |
| BIIB Biogen Inc | 1,272,500,000.0 | 1,221,000,000.0 | 1,104,000,000.0 |
| AZN AstraZeneca PLC | 5,134,000,000.0 | 3,408,000,000.0 | 1,048,000,000.0 |
| QGEN Qiagen NV | 165,019,000.0 | 114,572,000.0 | 621,779,000.0 |
| INCY 英賽德 | 559,389,000.0 | 544,642,000.0 | 500,036,000.0 |
| REGN 雷傑納榮製藥 | 1,618,700,000.0 | 1,374,000,000.0 | 497,500,000.0 |
| GMAB Genmab A/S | 536,000,000.0 | 534,000,000.0 | 465,000,000.0 |
| ALNY Alnylam Pharmaceuticals Inc | 325,109,000.0 | 312,967,000.0 | 376,941,000.0 |
| HALO Halozyme Therapeutics Inc | 178,597,000.0 | 175,567,000.0 | 357,804,000.0 |
| QURE Uniqure NV | -16,399,000.0 | -16,333,000.0 | 343,277,000.0 |
| EXEL Exelixis Inc | 290,322,000.0 | 288,840,000.0 | 211,867,000.0 |
| IMRX Immuneering Corp | -11,977,240.0 | -11,984,500.0 | 201,207,580.0 |
| IDYA IDEAYA Biosciences Inc | 142,214,000.0 | 142,172,000.0 | 184,282,000.0 |
| PHVS Pharvaris NV | -35,992,431.13 | -36,014,388.82 | 152,229,685.71 |
| CYTK Cytokinetics Inc | -107,505,000.0 | -116,859,000.0 | 152,028,000.0 |
| GLUE Monte Rosa Therapeutics Inc | 100,428,000.0 | 99,777,000.0 | 138,914,000.0 |
| SRRK Scholar Rock Holding Corp | -68,923,000.0 | -69,007,000.0 | 135,245,000.0 |
| EXAS Exact Sciences Corp | 219,923,000.0 | 190,026,000.0 | 131,938,000.0 |
| IMNM Immunome Inc | -40,510,000.0 | -41,626,000.0 | 128,763,000.0 |
| MESO Mesoblast Ltd | -29,299,000.0 | -29,873,000.0 | 123,522,000.0 |
| ILMN Illumina Inc | 284,000,000.0 | 253,000,000.0 | 116,000,000.0 |
| APLS Apellis Pharmaceuticals Inc | 108,468,000.0 | 108,320,000.0 | 109,135,000.0 |
| RNA Avidity Biosciences Inc | -156,173,000.0 | -160,060,000.0 | 106,251,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 108,734,000.0 | 108,663,000.0 | 100,949,000.0 |
| SRPT Sarepta Therapeutics Inc | -14,585,000.0 | -42,831,000.0 | 100,025,000.0 |
| ALKS Alkermes Plc | 101,672,000.0 | 84,358,000.0 | 95,250,000.0 |
| CRSP CRISPR Therapeutics AG | -84,634,000.0 | -84,708,000.0 | 92,879,000.0 |
| IMTX Immatics NV | -52,459,026.0 | -53,732,360.3 | 91,876,057.46 |
| MNPR Monopar Therapeutics Inc | -2,090,530.0 | 88,175,420.0 | |
| HCM HUTCHMED (China) Ltd | -73,391,000.0 | -74,725,000.0 | 86,392,000.0 |
| VTVT vTv Therapeutics Inc | -5,222,000.0 | 72,582,000.0 | |
| LGND Ligand Pharmaceuticals Inc | 15,907,000.0 | 15,892,000.0 | 71,707,000.0 |
| MYGN Myriad Genetics Inc | 21,100,000.0 | 14,900,000.0 | 71,100,000.0 |
| MNKD MannKind Corp | 23,640,000.0 | 22,515,000.0 | 70,388,000.0 |
| VKTX Viking Therapeutics Inc | -94,003,000.0 | 66,496,000.0 | |
| ANAB AnaptysBio Inc | -27,356,000.0 | -27,368,000.0 | 65,535,000.0 |
| DVAX Dynavax Technologies Corp | 33,829,000.0 | 32,592,000.0 | 61,146,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 39,681,000.0 | 39,494,000.0 | 53,899,000.0 |
| ASND Ascendis Pharma A/S | 2,526,717.74 | 2,464,518.0 | 52,865,084.68 |
| VRDN Viridian Therapeutics Inc | -84,611,000.0 | -84,738,000.0 | 52,323,000.0 |
| XOMA Xoma Royalty Corp | -296,000.0 | -296,000.0 | 52,068,000.0 |
| ANIP ANI Pharmaceuticals Inc | 44,055,000.0 | 37,952,000.0 | 44,813,000.0 |
| RCKT Rocket Pharmaceuticals Inc | -50,420,000.0 | -50,366,000.0 | 43,129,000.0 |
| RGEN Repligen Corp | 48,099,000.0 | 42,713,000.0 | 39,892,000.0 |
| KRYS Krystal Biotech Inc | 39,659,000.0 | 37,955,000.0 | 38,775,000.0 |
| NTLA Intellia Therapeutics Inc | -76,899,000.0 | -76,928,000.0 | 37,217,000.0 |
| BMRN BioMarin Pharmaceutical Inc | 368,685,000.0 | 334,935,000.0 | 36,292,000.0 |
| TVTX Travere Therapeutics Inc | 14,317,000.0 | -871,000.0 | 35,776,000.0 |
| SANA Sana Biotechnology Inc | -29,429,000.0 | -29,470,000.0 | 32,086,000.0 |
| FOLD Amicus Therapeutics Inc | 35,660,000.0 | 35,278,000.0 | 31,842,000.0 |
| ALEC Alector Inc | -32,511,000.0 | -32,522,000.0 | 31,732,000.0 |
| CGEM Cullinan Therapeutics Inc | -36,877,000.0 | 30,515,000.0 | |
| XFOR X4 Pharmaceuticals Inc | -27,822,000.0 | -27,822,000.0 | 30,413,000.0 |
| LXRX Lexicon Pharmaceuticals Inc | -23,833,000.0 | -23,833,000.0 | 28,292,000.0 |
| CGTX Cognition Therapeutics Inc | -5,651,000.0 | 28,266,000.0 | |
| CELC Celcuity Inc | -44,816,000.0 | -44,913,000.0 | 27,898,000.0 |
| CVAC CureVac NV | 35,044,272.38 | 34,666,379.62 | 27,446,515.46 |
| BIO.B Bio Rad Laboratories Inc | 120,900,000.0 | 89,200,000.0 | 26,500,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | -91,423,000.0 | -92,701,000.0 | 26,055,000.0 |
| EDIT Editas Medicine Inc | -30,843,000.0 | -31,276,000.0 | 25,899,000.0 |
| SABS SAB Biotherapeutics Inc | -13,050,020.0 | 25,732,490.0 | |
| IOVA Iovance Biotherapeutics Inc | -78,702,000.0 | -89,546,000.0 | 25,686,000.0 |
| CMPX Compass Therapeutics Inc. | -10,849,000.0 | -10,856,000.0 | 23,356,000.0 |
| ALGS Aligos Therapeutics Inc | -24,345,000.0 | -24,538,000.0 | 23,285,000.0 |
| MDXG MiMedx Group Inc | 29,329,000.0 | 29,135,000.0 | 23,214,000.0 |
| RLYB Rallybio Corp | -6,550,000.0 | 22,677,000.0 | |
| NCNA NuCana PLC | 1,718,769.42 | 1,655,559.59 | 22,602,221.34 |
| AXSM Axsome Therapeutics Inc | 1,046,000.0 | 988,000.0 | 22,256,000.0 |
| EQ Equillium Inc | -8,431,000.0 | -8,431,000.0 | 21,625,000.0 |
| TRDA Entrada Therapeutics Inc | -28,313,000.0 | -28,142,000.0 | 20,804,000.0 |
| ATXS Astria Therapeutics Inc | -32,295,000.0 | -32,295,000.0 | 19,961,000.0 |
| VCEL Vericel Corp | 22,082,000.0 | 19,452,000.0 | 19,871,000.0 |
| IBIO iBio Inc | -5,665,000.0 | -5,697,000.0 | 19,547,000.0 |
| BHVN Biohaven Ltd | -145,716,000.0 | -145,729,000.0 | 19,387,000.0 |
| TNGX Tango Therapeutics Inc | -30,952,000.0 | -31,103,000.0 | 19,066,000.0 |
| SLS Sellas Life Sciences Group Inc | -7,068,000.0 | 19,023,000.0 | |
| ATHE Alterity Therapeutics Ltd | -2,034,570.79 | -2,034,570.79 | 18,835,911.21 |
| BTAI BioXcel Therapeutics Inc | -18,787,000.0 | -18,787,000.0 | 18,745,000.0 |
| DARE Dare Bioscience Inc | -442,130.0 | -616,830.0 | 18,040,260.0 |
| CTKB Cytek Biosciences Inc | -3,897,000.0 | -4,552,000.0 | 17,810,000.0 |
| SPRO Spero Therapeutics Inc | 17,422,000.0 | 17,422,000.0 | |
| ACLX Arcellx Inc | -49,207,000.0 | -49,503,000.0 | 16,867,000.0 |
| TARS Tarsus Pharmaceuticals Inc | 18,257,000.0 | 16,347,000.0 | 16,076,000.0 |
| NVAX Novavax Inc | 107,804,000.0 | 105,787,000.0 | 14,375,000.0 |
| VTGN Vistagen Therapeutics Inc | -13,759,000.0 | -13,819,000.0 | 13,801,000.0 |
| KURA Kura Oncology Inc | -80,627,000.0 | -83,194,000.0 | 13,339,000.0 |
| CLDX Celldex Therapeutics Inc | -48,628,000.0 | -49,068,000.0 | 12,993,000.0 |
| INKT Mink Therapeutics Inc | -941,350.0 | 12,599,300.0 | |
| LEGN Legend Biotech Corp | 28,801,000.0 | 23,796,000.0 | 12,307,000.0 |
| INO Inovio Pharmaceuticals Inc | -21,573,490.0 | -21,641,440.0 | 12,216,040.0 |
| ADPT Adaptive Biotechnologies Corp | -7,127,000.0 | -7,536,000.0 | 11,840,000.0 |
| FBIO Fortress Biotech Inc | -6,110,000.0 | 11,832,000.0 | |
| ETON Eton Pharmaceuticals Inc | 12,026,000.0 | 11,742,000.0 | 11,742,000.0 |
| APVO Aptevo Therapeutics Inc | -6,688,000.0 | 11,651,000.0 | |
| JSPR Jasper Therapeutics Inc | -16,999,000.0 | -16,999,000.0 | 11,389,000.0 |
| IMCR Immunocore Holdings PLC | -4,456,000.0 | -5,204,000.0 | 10,480,000.0 |
| CERT Certara Inc | 32,314,000.0 | 25,522,000.0 | 10,445,000.0 |
| ARMP Armata Pharmaceuticals Inc | -4,298,000.0 | -4,540,000.0 | 10,428,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例